_HOME | _RSS
View Article
Switching From Tamoxifen to Exemestane in Estrogen-Receptor-Positive Breast Cancer
Wednesday, April 11, 2007 - 09:00 AM - 1 year, 9 months ago - Presse spécialisée - Medscape family medicine
Disease free survival rate improved, but difference in overall survival unknown. Gynecologic complications reduced, but osteoporosis and fractures increased. Journal Watch






